Purchases and Sales Made in Q4 2024 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q4 2024. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 05, 2025
Q4 2024
|
Us Bancorp \De\
|
SELL
|
- |
-7.16K- 36.42% |
$51.3K - $87.9K
|
12.5K
$76.2K
|
|
Jan 14, 2025
Q4 2024
|
Hennion & Walsh Asset Management, Inc.
|
SELL
|
- |
-15.5K- 4.4% |
$111K - $190K
|
336K
$2.05M
|
|
Jan 29, 2025
Q4 2024
|
Shaker Investments LLC
|
SELL
|
- |
-42.6K- 42.33% |
$306K - $523K
|
58.1K
$354K
|
|
Feb 03, 2025
Q4 2024
|
Hussman Strategic Advisors, Inc.
Ellicott City, MD |
SELL
|
- |
-63K- 42.86% |
$452K - $774K
|
84K
$512K
|
|
Jan 31, 2025
Q4 2024
|
Rice Hall James & Associates, LLC
|
SELL
|
- |
-84.6K- 5.04% |
$607K - $1.04M
|
1.59M
$9.73M
|
|
Jan 31, 2025
Q4 2024
|
New York State Common Retirement Fund
|
SELL
|
- |
-98.8K- 8.1% |
$709K - $1.21M
|
1.12M
$6.84M
|